Manufacturer record
SBS Biotech Mouza Rampur Jattan: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by SBS Biotech Mouza Rampur Jattan (Himachal Pradesh) was declared Not of Standard Quality in May 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L2001/17, Levetiracetam Injection (Nuatam Injection) (exp Dec 2021). RDTL Chandigarh (CDSCO lab) found it not of standard quality: Particulate matter. Listed in the May 2020 alert.
Records by type
1 record linked to SBS Biotech Mouza Rampur Jattan in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levetiracetam Injection (Nuatam Injection) | Batch L2001/17Mfg Jan 2020 · Exp Dec 2021 | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.